Novel	JJ	novel JJ PennPOS
pharmacological	JJ	pharmacological JJ PennPOS
approaches	NNS	approach n2 NUPOS
to	TO	to p-acp NUPOS
manage	VB	manage VBP PennPOS
interstitial	JJ	interstitial JJ PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
twenty-first	JJ	twenty-first JJ PennPOS
century	NN	century NN PennPOS
.	.	. . NUPOS

Pharmacological	JJ	pharmacological JJ PennPOS
agents	NNS	agent NNS PennPOS
currently	RB	current av-j NUPOS
in	IN	in IN PennPOS
use	NN	use NN PennPOS
to	TO	to p-acp NUPOS
treat	VB	treat VBP PennPOS
interstitial	JJ	interstitial JJ PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
are	VBP	be vbb NUPOS
either	CC	either CC PennPOS
ineffective	JJ	ineffective JJ PennPOS
or	CC	or cc NUPOS
too	RB	too av NUPOS
toxic	JJ	toxic JJ PennPOS
in	IN	in IN PennPOS
humans	NNS	human NNS PennPOS
.	.	. . NUPOS

This	DT	this d NUPOS
review	NN	review NN PennPOS
addresses	NNS	address n2 NUPOS
mechanistically	RB	mechanistic av-j NUPOS
based	VBN	base vvn NUPOS
novel	JJ	novel JJ PennPOS
approaches	NNS	approach n2 NUPOS
that	WDT	that WDT PennPOS
have	VBP	have vhb NUPOS
the	DT	the dt NUPOS
potential	JJ	potential JJ PennPOS
to	TO	to p-acp NUPOS
minimize	VB	minimize VBP PennPOS
the	DT	the dt NUPOS
accumulation	NN	accumulation NN PennPOS
of	IN	of pp-f NUPOS
collagen	NN	collagen NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
lung	NN	lung NN PennPOS
,	,	, , NUPOS
a	DT	a dt NUPOS
hallmark	NN	hallmark NN PennPOS
of	IN	of pp-f NUPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

These	DT	these d NUPOS
approaches	NNS	approach n2 NUPOS
include	VBP	include VBP PennPOS
maintaining	VBG	maintain VBG PennPOS
the	DT	the dt NUPOS
intracellular	JJ	intracellular JJ PennPOS
levels	NNS	level NNS PennPOS
of	IN	of pp-f NUPOS
NAD	NNP	nad NN PennPOS
(	(	( ( NUPOS
+	CC	+ CC PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
ATP	NN	atp NN PennPOS
,	,	, , NUPOS
blocking	VBG	block VBG PennPOS
the	DT	the dt NUPOS
biological	JJ	biological JJ PennPOS
activities	NNS	activity NNS PennPOS
of	IN	of pp-f NUPOS
TGF-beta	NN	TGF-beta NN PennPOS
and	CC	and cc NUPOS
integrins	NNS	integrin NNS PennPOS
,	,	, , NUPOS
evaluating	VBG	evaluate VBG PennPOS
the	DT	the dt NUPOS
effectiveness	NN	effectiveness NN PennPOS
of	IN	of pp-f NUPOS
PAF-receptor	NN	PAF-receptor NN PennPOS
antagonists	NNS	antagonist NNS PennPOS
and	CC	and cc NUPOS
NOS	NN	nos NN PennPOS
inhibitors	NNS	inhibitor NNS PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
developing	VBG	develop VBG PennPOS
a	DT	a dt NUPOS
new	JJ	new JJ PennPOS
generation	NN	generation NN PennPOS
of	IN	of pp-f NUPOS
cysteine	NN	cysteine NN PennPOS
pro-drugs	NNS	pro-drug NNS PennPOS
with	IN	with pp NUPOS
an	DT	a dt NUPOS
adequate	JJ	adequate JJ PennPOS
degree	NN	degree NN PennPOS
of	IN	of pp-f NUPOS
bioavailability	NN	bioavailability NN PennPOS
.	.	. . NUPOS

A	DT	a dt NUPOS
critical	JJ	critical JJ PennPOS
analysis	NN	analysis NN PennPOS
of	IN	of pp-f NUPOS
each	DT	each d NUPOS
approach	NN	approach NN PennPOS
as	IN	as c-acp NUPOS
it	PRP	it pn31 NUPOS
relates	VBZ	relate VBZ PennPOS
to	TO	to p-acp NUPOS
management	NN	management NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
in	IN	in IN PennPOS
humans	NNS	human NNS PennPOS
is	VBZ	be vbz NUPOS
presented	VBN	present VBN PennPOS
.	.	. . NUPOS

